UK approves a sixth covid vaccine – Hello, Valneva!
We are still in an “acute phase of the pandemic”, as the more transmissible omicron variant and its sublineages spread across the world.
Tedros Adhanom Ghebreyesus, WHO.
The UK has approved another covid vaccine, Valneva, this time containing an entire inactivated covid virus. It can be stored in an ordinary fridge for up to a year, which means it’s a lot more convenient and practical than other vaccines. The mRNA vaccines by Moderna and Pfizer/BioNTech, for example, have to be stored at -20°C, and can only be stored for a maximum of six months frozen. Once defrosted they only have a short useful life. Oxford/AstraZeneca can also be stored at higher temperatures.
Bahrain was the first to approve it for emergency use in March this year. The UK is the first in Europe to sign on the dotted line. The decision follows a promising study in 2021, where two doses of the new Valneva jab, 28 days apart, provided 40% more neutralising antibodies than Oxford/AstraZeneca. The rate of covid infections was similar between the two groups, with no severe disease in any of the 4012 participants. The vaccine is approved for people aged 18 – 50, with two doses taken at least 28 days apart.
At the same time Pfizer’s chief executive says they will develop a covid vaccine that protects people against all known variants by the end of 2022. And that will be very good news indeed.
More covid news for week 3 April 2022
- People with an increased risk of heart disease are as much as 600% more likely to die from covid
- People with more than 10% risk of stroke or heart attack over the next decade are nearly three times more likely to be admitted to intensive care with covid.
- The USA has just extended its public health emergency, which was due to end on 16th April
- More than 500 million covid cases have been recorded globally since the outbreak – but the real number will be a lot higher
- The number of new worldwide cases has been falling... or has it? Experts put the fall down to ‘reduced testing and a subsequent underreporting of cases’
- Israel has analysed its booster campaign to find the timing of booster roll-outs is crucial to preventing surges, especially when infections are ‘growing exponentially’
- In England we’ve seen a 26% week-on-week reduction in new cases
- Medics are investigating a potential surge in liver inflammation – also called hepatitis – in UK children, with 74 cases so far in 2022. Some say it might be a rare delayed reaction to covid infection
- Heart inflammation after a jab is probably no more likely than after any other kind of vaccination – the research continues
- Two new subvariants of omicron, BA.4 ad BA.5, are being examined to check they’re no more infectious or dangerous than the others, and whether they can evade immunity better
Have you seen our post about the latest Far UVC and UVC disinfection news? It’s inspiring. Take a look, then give us a call to begin your journey to better covid safety.









